Viral Infection-A Looming Catastrophe

Sachin C. Joshi, Amit V. Kakad, Vardhaman A. Murkunde, Gayatri Kanade
{"title":"Viral Infection-A Looming Catastrophe","authors":"Sachin C. Joshi, Amit V. Kakad, Vardhaman A. Murkunde, Gayatri Kanade","doi":"10.54037/wjps.2022.100405","DOIUrl":null,"url":null,"abstract":"The common cold, influenza, chickenpox, human immunodeficiency virus (HIV), SARS-CoV-2, and other disease-causing (pathogenic) viruses crop up when most people hear the word \"virus.\" Infectious diseases are predicted to account for over one-third (i.e., 20 million) of annual deaths worldwide, as per the World Health Organization (WHO). The rising globalized health sector has made major contributions to the improvement of human health. However, long-standing, developing, and re-emerging infectious disease risks continue to haunt the globe. With a pandemic on the scale of COVID-19, Antibiotic resistance is a veiled concern looming behind the COVID-19 pandemic, which has already claimed thousands of lives before the global breakout. With the worrisome rise in antibiotic resistance incidences only few new antimicrobial drugs on the horizon, it's essential to keep monitor of pathogen epidemiology in ways that will improve treatment decisions. This review article aimed to outline recent findings of the origin, transmission, diagnosis, precautionary measures, antimicrobial resistance, reinfection and repurposing of drugs for the treatment and prevention of COVID-19 depending on the previous literature.","PeriodicalId":23975,"journal":{"name":"World journal of Pharmacy and pharmaceutical sciences","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of Pharmacy and pharmaceutical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54037/wjps.2022.100405","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The common cold, influenza, chickenpox, human immunodeficiency virus (HIV), SARS-CoV-2, and other disease-causing (pathogenic) viruses crop up when most people hear the word "virus." Infectious diseases are predicted to account for over one-third (i.e., 20 million) of annual deaths worldwide, as per the World Health Organization (WHO). The rising globalized health sector has made major contributions to the improvement of human health. However, long-standing, developing, and re-emerging infectious disease risks continue to haunt the globe. With a pandemic on the scale of COVID-19, Antibiotic resistance is a veiled concern looming behind the COVID-19 pandemic, which has already claimed thousands of lives before the global breakout. With the worrisome rise in antibiotic resistance incidences only few new antimicrobial drugs on the horizon, it's essential to keep monitor of pathogen epidemiology in ways that will improve treatment decisions. This review article aimed to outline recent findings of the origin, transmission, diagnosis, precautionary measures, antimicrobial resistance, reinfection and repurposing of drugs for the treatment and prevention of COVID-19 depending on the previous literature.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
病毒感染——迫在眉睫的灾难
当大多数人听到“病毒”这个词时,就会想到普通感冒、流感、水痘、人类免疫缺陷病毒(HIV)、SARS-CoV-2和其他致病(致病性)病毒。根据世界卫生组织(卫生组织)的数据,传染病预计将占全世界每年死亡人数的三分之一以上(即2 000万人)。日益全球化的卫生部门为改善人类健康作出了重大贡献。然而,长期存在、正在发展和重新出现的传染病风险继续困扰着全球。在COVID-19大规模流行的情况下,抗生素耐药性是隐藏在COVID-19大流行背后的隐忧,在全球爆发之前,这种大流行已经夺去了数千人的生命。随着抗生素耐药性发病率令人担忧的上升,只有少数新的抗菌药物即将出现,必须以改善治疗决策的方式监测病原体流行病学。这篇综述文章旨在根据以往文献概述COVID-19的起源、传播、诊断、预防措施、抗菌素耐药性、再感染和治疗和预防药物再利用的最新发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Nutraceuticals aid in managing COVID-19 Clinical Efficacy of Simhyadi Kwathalong with Shati Churnain Tamaka Shwasa (Bronchial Asthma) Formulation and evaluation of Lamivudinefloating tablets usingCarbopol & Eudragit S 100 Development and Validation of Stability Indicating Analytical Method for the Simultaneous Estimation of Netarsudil and Latanoprost by RP-HPLC Viral Infection-A Looming Catastrophe
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1